Autoplaque vs Vivid iq
AI Verdict
Choose Autoplaque if…
Choose Autoplaque if your primary need is detailed, AI-driven quantitative analysis of coronary plaques and luminal stenoses from existing CT angiography images. This tool is ideal for clinicians seeking precise measurements and characterization of atherosclerotic plaque to enhance heart attack risk prediction and guide treatment strategies based on static imaging data.
View Autoplaque →Choose Vivid iq if…
Choose Vivid iq if you require a portable, real-time cardiovascular ultrasound system for immediate diagnostic imaging across various clinical settings. This device is best suited for scenarios demanding high-resolution 2D and 4D imaging with advanced quantification directly at the patient's bedside or in emergency situations where dynamic assessment is crucial.
View Vivid iq →Reviewed by Pouyan Golshani, MD — Interventional Radiologist
Quick Comparison
| Feature | Autoplaque | Vivid iq |
|---|---|---|
| Pricing | Unknown | Starts at $7,650 (refurbished) to $38,388 (new). leasing options start at $547.82/month or $999/month. |
| Deployment | Workstation-based post-processing application, runs on Windows or Mac OS. | On-premise |
| BAA Available | Unknown | Yes AI-estimated |
| FDA Status | Cleared AI-estimated | Cleared AI-estimated |
| HIPAA | Unknown | Yes AI-estimated |
Head-to-Head
AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.
Usability
Vivid iqVivid iq is an ultra-portable device with an intuitive touchscreen interface and tablet-like gestures, designed for efficient workflow and use in various settings. Its AI-powered tools significantly reduce keystrokes and exam times, enhancing on-the-go usability. Autoplaque, while streamlining complex analysis, is workstation-based software.
Clinical Value
AutoplaqueAutoplaque provides highly specialized, FDA-cleared AI-powered quantitative analysis of coronary plaques and luminal stenoses from CT angiography, directly aiding in heart attack risk prediction and treatment guidance. This offers a unique and critical clinical insight that is difficult and time-consuming to achieve manually. Vivid iq offers broad diagnostic capabilities with excellent imaging, but Autoplaque's specific, high-impact risk prediction capability gives it an edge.
Pricing & Value
Vivid iqVivid iq offers greater pricing transparency, with previously observed sale prices ranging from $12,999 to over $40,000, and options for leasing or renting the device. Autoplaque's pricing is not disclosed, making it impossible to assess its value proposition or compare costs effectively.
Enterprise Readiness
Vivid iqVivid iq, from GE HealthCare, explicitly states HIPAA compliance and BAA availability, and offers robust DICOM connectivity and IHE Integration Statements, which are essential for seamless integration into enterprise healthcare systems. Autoplaque, while FDA-cleared, lacks disclosed information on these critical enterprise features.
Innovation
AutoplaqueAutoplaque's innovation lies in its highly specialized, AI-driven quantitative analysis of coronary plaque from CT angiography, which significantly improves heart attack risk prediction and automates a previously time-consuming manual process. While Vivid iq innovates with AI in portable ultrasound, Autoplaque's focus on a very specific, high-impact diagnostic challenge with AI-driven precision for risk stratification demonstrates a more specialized innovation.
Support & Docs
Vivid iqAs a product from GE HealthCare, Vivid iq benefits from a well-established infrastructure for comprehensive support, extensive documentation including manuals and tutorials, and service programs like loaner devices. Autoplaque, originating from a medical center, does not have publicly available details on comparable commercial support.
Feature-by-Feature
Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.
| Feature | Autoplaque | Vivid iq |
|---|---|---|
| Name | Autoplaque | Vivid iq |
| Company | Cedars-Sinai Medical Center: AIM | GE Medical Systems Ultrasound and Primary Care Diagnostics |
| Tagline | AI-Powered Quantitative Analysis for Coronary Plaque and Stenosis | Portable. Powerful. In touch. Exceptional 2D and 4D imaging wherever you need it. |
| Primary Function | AI-powered software for quantitative analysis of coronary plaques and luminal stenoses from CT angiography images. | AI-powered, ultra-portable cardiovascular ultrasound system offering high-resolution 2D and 4D imaging with advanced quantification tools. |
| Key Features (Specific Functionality) | AI-powered quantitative analysis of atherosclerotic plaque; Measurement of luminal stenoses; Automated vessel, plaque, and lumen segmentation. | High-resolution 2D and 4D imaging; Advanced quantification tools. |
Videos
Demos, reviews, and walkthroughs featuring Autoplaque and Vivid iq.